Clinical Outcomes and Cost of Gram Negative Bacteremia

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

NCT06966284 ·Status: RECRUITING

Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

NCT01041716 ·Status: COMPLETED

Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia

NCT01737320 ·Status: COMPLETED ·Phase: NA

Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection

NCT02482961 ·Status: COMPLETED

Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn

NCT02653157 ·Status: COMPLETED

Nebulized Colistin for Gram Negative VAP Prevention.

NCT04208945 ·Status: UNKNOWN ·Phase: NA

Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit

NCT05171257 ·Status: COMPLETED

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

NCT06080698 ·Status: RECRUITING ·Phase: NA

A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

NCT01970371 ·Status: COMPLETED ·Phase: PHASE3

Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections

NCT04552444 ·Status: UNKNOWN

Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

NCT03007290 ·Status: COMPLETED ·Phase: NA

Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria

NCT02328183 ·Status: UNKNOWN ·Phase: PHASE4

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

NCT03622918 ·Status: COMPLETED ·Phase: NA

Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections

NCT01314053 ·Status: UNKNOWN

Catheter Related - Gram Positive Bloodstream Infections

NCT00467272 ·Status: COMPLETED ·Phase: PHASE2

Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

NCT04489459 ·Status: UNKNOWN ·Phase: PHASE4

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT06069206 ·Status: COMPLETED ·Phase: NA

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

NCT01191840 ·Status: COMPLETED ·Phase: PHASE2

Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia

NCT03745014 ·Status: WITHDRAWN ·Phase: NA

Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections

NCT05942157 ·Status: RECRUITING ·Phase: NA

Epidemiology of Klebsiella Pneumoniae in China

NCT03598543 ·Status: UNKNOWN

Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection

NCT00304811 ·Status: COMPLETED ·Phase: PHASE4

Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations

NCT04573894 ·Status: COMPLETED

Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin

NCT00414362 ·Status: COMPLETED

Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

NCT00296049 ·Status: WITHDRAWN ·Phase: NA